EphA2- and HDAC-Targeted Combination Therapy in Endometrial Cancer.
Joseph R, Dasari SK, Umamaheswaran S, Mangala LS, Bayraktar E, Rodriguez-Aguayo C, Wu Y, Nguyen N, Powell RT, Sobieski M, Liu Y, Kim MS, Corvigno S, Foster K, Hanjra P, Vu TC, Chowdhury MA, Amero P, Stephan C, Lopez-Berestein G, Westin SN, Sood AK.
Joseph R, et al. Among authors: corvigno s.
Int J Mol Sci. 2024 Jan 20;25(2):1278. doi: 10.3390/ijms25021278.
Int J Mol Sci. 2024.
PMID: 38279277
Free PMC article.